Intellectual Property India Publishes Patent Application for 2-(4-(2-(7,8-Dimethyl-[1,2,4]triazolo[1,5-A]pyridin-6-Yl)-3-Isopropyl- 1h-Indol-5-Yl)piperidin-1- Yl)acetamide And Crystalline Forms Thereof

MUMBAI, India, Sept. 7 -- Intellectual Property India has published a patent application (202617047438 A) filed by Bristol-Myers Squibb Company on April 14, 2026, for 2-(4-(2-(7,8-Dimethyl-[1,2,4]triazolo[1,5-A]pyridin-6-Yl)-3-Isopropyl- 1h-Indol-5-Yl)piperidin-1- Yl)acetamide And Crystalline Forms Thereof.

Inventors include Gao, Qi; Zhao, Rulin; and Mbachu, Victoria A.

The application for the patent was published on September 04, 2026, under issue no. 36/2026.

Abstract: Disclosed are a free base hemihydrate and free base anhydrates of 2?(4?(2?(7,8?dimethyl?[1,2,4]triazolo[1,5?a]pyridin?6?yl)?3?isopropyl?1H?indol?5?yl) piperidin?1?yl)acetamide, and crystalline forms thereof.

Disclaimer: Curated by HT Syndication.